Frier Levitt is a national boutique healthcare law firm, providing comprehensive regulatory,

transactional and litigation counsel to the Healthcare and Life Sciences industries.

Frier Levitt is a national boutique healthcare law firm, providing comprehensive regulatory, transactional and litigation counsel to the Healthcare and Life Sciences industries.

Page 1 Created with Sketch.

Pharmacy Law

  • Defending Pharmacies in PBM Audits
  • Community, Retail Pharmacies
  • Criminal Defense and Government Investigations
  • Specialty Pharmacies
  • DIR Fees
  • Antitrust Tools Available to Combat PBM Abuse of Pharmacies
  • Medicare Audit Appeals
  • Maximum Allowable Cost (MAC) Pricing and Appeals
  • Chain Pharmacies
  • Section 340B In-House and Contract Pharmacies
  • Telehealth
  • Manufacturers / Repackagers
  • Pharmaceutical Wholesalers
  • Private Equity Investing in Specialty Pharmacy and Pharmaceutical Companies
  • Traditional Compounding Pharmacies (503A)
  • Outsourcing Facilities (503B)
  • Veterinary Compounders
Learn More
 
Page 1 Created with Sketch.

Healthcare Law

  • Medical Practice Mergers and Super Groups
  • White Collar Criminal Defense and Government and Internal Investigations
  • Healthcare Litigation
  • Professional Practice Representation
  • Hospital/Physician Negotiations and Joint Ventures
  • Ambulatory Care Facility Formation and Representation
  • Federal and State Fraud and Abuse Counseling
  • Pain Management Compliance
  • Managed Care Negotiations and Strategies
  • Clinically Integrated Networks (CINs)
  • Medicare and Insurance Audits
  • HIPAA and HITECH Compliance
  • Out-of-Network Provider Issues
  • Dental Practices
  • Professional Board Actions
  • Telehealth
  • Skilled Nursing Facilities and Long Term Care
  • Laboratories
  • Healthcare Private Equity Services
  • Administrative and Insurance Defense Law
  • Clinical Trials / Human Subjects Research
  • In-house Counsel Legal Support Services
Learn More
 

Latest Articles

PH
Jun 17th 2019 - Surprise Cuts in Medicaid Reimbursements and the Impact on Independent Pharmacies
PH
Jun 14th 2019 - FDA Conducts Anticipated Hearing on the Regulation of CBD Products
View All   >

Latest Tweets

View All   >